Анестезиология и реаниматология 1-2, 2018 Анестезиология и реаниматология

terapii.
2017;1:5-11.].
24. da Luz LT, Nascimento B, Rizoli S. Thrombelastography (TEG(R)): prac-
tical considerations on its clinical use in trauma resuscitation. Scand J Trau-
ma Resusc Emerg Med.
2013;21:29.
25. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guid-
ed transfusion protocol during aortic surgery with circulatory arrest: a pro-
spective, randomized trial. J Thorac Cardiovasc Surg. 2010;140:1117-1124; 
e1112.
26. Trzebicki J, Flakiewicz E, Kosieradzki M, et al. The use of thromboelastom-
etry in the assessment of hemostasis during orthotopic liver transplantation 
reduces the demand for blood products. Ann Transplant. 2010;15:19-24.
27. Walker C, Ingram M, Edwards D, Wood P. Use of thromboelastometry in 
the assessment of coagulation before epidural insertion after massive trans-
fusion. Anaesthesia. 2011;66:52-55.
28. Doran CM, Woolley T, Midwinter MJ. Feasibility of using rotational throm-
boelastometry to assess coagulation status of combat casualties in a deployed 
setting. J Trauma. 2010;69(suppl 1):40-48.
29. Lee SH, Lee SM, Kim CS, et al. Use of fibrin-based thromboelastometry 
for cryoprecipitate transfusion in cardiac surgery involving deep hypother-
mic circulatory arrest during cardiopulmonary bypass. Blood Coagul Fibri-
nolysis.
2010;21:687-691.
30. Wada H, Thachil J, Di Nisio M, Kurosawa S, Gando S, Toh CH. Harmo-
nized guidance for disseminated intravascular coagulation from the Interna-
tional Society on Thrombosis and Haemostasis and the current status of an-
ticoagulant therapy in Japan: a rebuttal. Scientific and Standardization Com-
mittee on DIC of the International Society on Thrombosis and Haemostasis. 
J Thromb Haemost. 
2013;11(11):2078-2079.
31. Тромбоз и гемостаз. Шкалы и алгоритмы. Пособие. Под ред. Ройтмана 
Е.В. и Левшина Н.Ю. М. 2016. [Tromboz i gemostaz. Syhkaly i algoritmy. 
Posobie. Pod red. Rojtmana E.V. i Levshina N.Yu. M. 2016.].
32. Stravitz TR, Lisman T, Luketic VA, et al. Minimal effects of acute liver in-
jury/acute liver failure on hemostasis as assessed by thromboelastography. J 
Hepatol. 
2011;56:129-136.
33. Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities 
in Acute Liver Failure. J Hepatol. 2012;57:780-786.
34. Wada H, Asakura H, Okamoto K, Iba T, Uchiyama T, Kawasugi K, Koga S, 
Mayumi T, Koike K, Gando S, Kushimoto S, Seki Y, Madoiwa S, Maruyama I, 
Yoshioka A, Japanese Society of Thrombosis Hemostasis/DIC subcommit-
tee. Expert consensus for the treatment of disseminated intravascular coag-
ulation in Japan. Thromb Res. 2010;125:6-11.
35. British Committee for Standards in Haematology. Guidelines for the diag-
nosis and management of disseminated intravascular coagulation. British 
Journal of Haematology.
2009;145:24-33.
36. Kawasugi K, Wada H, Hatada T, Okamoto K, Uchiyama T, Kushimoto S, Se-
ki Y, Okamura T, Nobori T, Japanese Society of Thrombosis Hemostasis/DIC 
subcommittee. Prospective evaluation of hemostatic abnormalities in overt 
DIC due to various underlying diseases. Thromb Res. 2011;128:186-190.
37. Pernerstorfer T, Hollenstein U, Hansen J, Knechtelsdorfer M, Stohlawetz P, 
Graninger W, Eichler HG, Speiser W, Jilma B. Heparin blunts endotoxin-
induced coagulation activation. Circulation. 1999;100:2485-2490.
38. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Ather-
stone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schin-
del F, Juers M, Bone RC, Opal SM. Caring for the critically ill patient. High-
dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 
2001;286:1869-1878.
39. Aoki N, Matsuda T, Saito H, Takatsuki K, Okajima K, Takahashi H, Taka-
matsu J, Asakura H, Ogawa N, CTC-111-IM Clinical Research Group. A 
comparative double-blind randomized trial of activated protein C and un-
fractionated heparin in the treatment of disseminated intravascular coagula-
tion. Int J Hematol. 2002;75:540-547.
40. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hi-
rayama A, Matsuda T, Asakura H, Nakashima M, Aoki N. Efficacy and safe-
ty of recombinant human soluble thrombomodulin (ART-123) in dissemi-
nated intravascular coagulation: results of a phase III, randomized, double-
blind clinical trial. J Thromb Haemost. 2007;5:31-41.
41. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N